Core Insights - The article emphasizes the potential of investing in dividend ETFs as a strategy for generating income and growing a portfolio over time [1] Group 1: Dividend ETFs Overview - The State Street SPDR S&P Dividend ETF (SDY) has 155 high-quality holdings and offers a 2.35% annual yield, focusing on companies that have consistently increased dividends for at least 20 years [1] - The Vanguard High Dividend Yield ETF (VYM) features a low expense ratio of 0.04% and a 2.33% dividend yield, with a diverse holdings list of 562 companies, including major market players [1] - The iShares International Select Dividend ETF (IDV) provides a 4.63% dividend yield with a focus on established international companies, despite a higher expense ratio of 0.5% [1][2] Group 2: Performance Metrics - The SDY ETF's share price has increased by 40% over the past five years, indicating strong growth potential alongside its dividend yield [1] - The VYM ETF has seen a remarkable 63% increase in share price over the last five years, excluding dividend payments [1] - The IDV ETF's share price has grown by 42% in the past five years, showcasing its potential for both dividend income and capital appreciation [2]

Caterpillar Inc. (NYSE:CAT) is one of the stocks Jim Cramer commented on. Cramer mentioned the stock during the episode and commented: What else do we need so badly that we’ll pay anything for? Well, how about Caterpillar? We like their stuff. Turbines, GE Vernova. Hey, how about things that move other things? FedEx is good, any trucker. How about value-oriented companies like Walmart, Dollar General, Costco, Dollar Tree, TJX, they report tomorrow. All those companies make things and sell them cheaper tha ...

Quick Read iShares Consumer Staples (KXI) returned 18.07% over the past year with lower volatility than the S&P 500’s 15.11%. Walmart and Costco represent KXI’s largest positions at 9.94% and 9.22%. KXI charges a 0.39% expense ratio versus XLP’s 0.08%. Nvidia made early investors rich, but there is a new class of 'Next Nvidia Stocks' that could be even better; learn more here. Consumer sentiment has been sitting in recessionary territory for months, with the University of Michigan's index at 56. ...

Core Viewpoint - KP Tissue Inc. reported strong earnings per share (EPS) but fell short on revenue expectations, indicating mixed financial performance in a competitive market [1][4]. Financial Performance - The company announced an EPS of $0.43, significantly exceeding the estimated EPS of $0.18 [1][4]. - Revenue for the period was reported at $407.8 million, which did not meet the forecasted revenue of $553.2 million [1][4]. - The company has a price-to-earnings (P/E) ratio of 27.49, reflecting strong investor confidence in its future earnings potential [2]. - An earnings yield of 3.64% was reported, indicating a favorable return on investment for shareholders [2]. Financial Stability - KP Tissue maintains a current ratio of 1, demonstrating its capability to cover short-term liabilities with short-term assets [3][4].

Core Viewpoint - Altria Group is considered a strong buy-and-hold investment despite controversies surrounding its tobacco business, with a history of benefiting long-term investors [1]. Financial Performance - Altria shares have generated annualized returns of nearly 18% over the past five years, outperforming the S&P 500's annualized total returns of around 13% during the same period [2]. - The company has a market capitalization of $112 billion, with a current stock price of $66.54 and a dividend yield of 6.25% [3]. - Altria's total returns since February 2021 have reached 128.6%, significantly higher than the S&P 500's 85.8%, Coca-Cola's 81.7%, and Procter & Gamble's 41.6% [6]. Dividend Growth - Altria is classified as a "Dividend King," having over 50 years of consecutive dividend growth, with a forward dividend yield of 6.3% [5]. - The company has maintained steady earnings and dividend growth in the low single-digit range, primarily through price increases on smokeable products [10]. Market Position and Challenges - Altria generates approximately 88% of its total net revenue from smokeable products, lagging behind competitors like Philip Morris International, which derives around 41.5% of its revenue from smoke-free products [7][8]. - Past investments in smoke-free products, such as Juul Labs and Njoy, have resulted in significant impairment losses and legal challenges [9]. Future Outlook - Altria's modest earnings growth is expected to support its 6.3% dividend, positioning the company for solid returns in the future [11]. - The potential for valuation expansion exists, as Altria currently trades at 12 times forward earnings compared to Philip Morris International's 22 times [13]. - The company could enhance its nicotine pouch business through acquisitions, which may lead to stronger earnings growth and improved stock performance [12].

Core Viewpoint - The SPDR Portfolio S&P 500 Value ETF (SPYV) has outperformed the S&P 500 index over the past year, returning 13.81% compared to the S&P 500's 11.81%, but has significantly lagged behind growth stocks over the past five years [1]. Group 1: Performance Comparison - SPYV returned 13.81% over the past year, while the S&P 500 returned 11.81% and the SPDR Portfolio S&P 500 Growth ETF (SPYG) returned 12.46% [1]. - Over five years, SPYV delivered total returns of 233.53%, significantly lower than SPYG's 399.44% [1]. - Year-to-date, SPYV is up 3.84%, contrasting with SPYG's decline of 3.46%, indicating value's potential to outperform during growth stock downturns [1]. Group 2: Investment Characteristics - SPYV focuses on companies with reasonable valuations and steady cash flows, making it suitable for investors seeking stability and income [1]. - The fund has a dividend yield of 1.77% and a low expense ratio of 0.04%, which is beneficial for long-term after-tax returns [1]. - The portfolio includes established companies like Apple (16.7% allocation), Walmart, and Exxon Mobil, providing a mix of technology and defensive cash flows [1]. Group 3: Investment Strategy and Risks - Investing in SPYV involves accepting lower long-term growth potential in exchange for valuation discipline and income generation [1]. - The fund has a concentration risk, with the top ten holdings representing approximately 23% of its assets [1]. - SPYV is designed for investors prioritizing stability and dividends over maximum capital appreciation, requiring patience during growth rallies [1].

Core Viewpoint - L'Oréal is a leading global cosmetics company facing competition but has received a positive stock upgrade from HSBC, indicating a favorable outlook for future performance [1][6] Company Performance - L'Oréal reported total sales of $52.29 billion last year, reflecting a 1.3% increase on a like-for-like basis, supporting an optimistic outlook for 2026 [4][6] - The current stock price is $89.06, which represents a 2.70% increase, with a trading range between $88.16 and $89.43 [4] Market Position - L'Oréal's market capitalization is approximately $237.69 billion, highlighting its significant presence in the cosmetics industry [5] - The stock has shown volatility over the past year, with a high of $95.10 and a low of $69.35, indicating potential for momentum investing [5] Investment Sentiment - Despite recent challenges, L'Oréal is viewed as a strong candidate for momentum investors, holding a Momentum Style Score of B, suggesting it is well-positioned for those looking to capitalize on stock trends [3][6] - The company has faced a decline in stock value due to weaker-than-expected performance at the end of the previous year, impacting investor sentiment [2]

Group 1 - The Coca-Cola Company (NYSE:KO) is highlighted in Jim Cramer's game plan, particularly noting the retirement of CEO James Quincey, marking his last quarter in charge [1] - Cramer mentioned that Coca-Cola does not have a snack business like PepsiCo, which has seen growth due to price cuts, indicating a different market strategy for Coca-Cola [1] - Coca-Cola's major brands include Coca-Cola, Fanta, Sprite, Dasani, and others, positioning the company as a significant player in the beverage industry [3] Group 2 - Cramer identified Coca-Cola as one of his top three picks for dividend stocks, alongside Kimberly and Procter & Gamble, despite a general lack of strong dividend stocks in the current market [3] - The company is recognized for its diverse beverage portfolio, which includes soft drinks, water, juices, coffee, tea, sports drinks, and plant-based beverages [3]

Core Insights - Edgewell Personal Care Company reported a Q1 fiscal 2026 GAAP EPS of -$1.41, impacted by the divestiture of its Feminine Care business, while adjusted EPS from continuing operations was -$0.16, outperforming the Zacks Consensus Estimate of -$0.18, resulting in an earnings surprise of 11.11% [1] - Revenue for the period was $422.8 million on a continuing operations basis, a 1.9% year-over-year increase, but below the Zacks Consensus Estimate of approximately $481.3 million, representing a 12.15% miss [2] - The company completed the divestiture of its Feminine Care business to Essity for $340 million, which is seen as a strategic move to focus on core areas and strengthen its balance sheet [3] Financial Performance - On a consolidated basis, net sales were $486.8 million, reflecting a 1.8% increase from the prior year, while organic net sales decreased by 0.5% on a continuing operations basis [2] - The company has exceeded consensus revenue estimates only once in the past four quarters, indicating ongoing challenges in meeting market expectations [2] - Financial ratios post-divestiture show a negative trailing P/E ratio of approximately -23.96, a P/S ratio of 0.42, a debt-to-equity ratio of 1.05, and a current ratio of 2.12, suggesting solid short-term financial health [5] Strategic Developments - The divestiture of the Feminine Care business is viewed as a pivotal milestone in the company's transformation, positioning Edgewell as a more focused and agile organization [3] - The company operates in a competitive consumer products industry, facing rivals such as Procter & Gamble and Unilever, and its Q1 performance modestly exceeded internal expectations for organic net sales, adjusted EPS, and adjusted EBITDA [4]

Core Viewpoint - e.l.f. Beauty Inc. has demonstrated resilience in the cosmetics industry, consistently growing its quarterly sales for 27 consecutive quarters despite recent earnings misses and competitive pressures [1][2]. Financial Performance - For the quarter ending February 4, 2026, e.l.f. Beauty reported earnings per share (EPS) of $0.68, below the expected $0.72, with revenue of approximately $344 million, falling short of the estimated $462 million [2]. - The company has a price-to-earnings (P/E) ratio of about 60.49, indicating that investors are willing to pay a premium for its earnings, while the price-to-sales ratio is approximately 3.65 and the enterprise value to sales ratio is around 4.17 [3]. Financial Health - e.l.f. Beauty's debt-to-equity ratio is approximately 0.81, suggesting a moderate level of debt financing, and the current ratio stands at about 2.70, indicating a strong ability to cover short-term liabilities with short-term assets [4]. Market Outlook - Analysts had anticipated a decline in e.l.f. Beauty's earnings for the quarter ending December 2025, despite an expected increase in revenues, with future earnings outlook and stock price movements dependent on management's discussion during the earnings call [5].